Citation

Publication Date: 2011-06-01
Format: Journal Article
Bibliography: Felix W. Frueh, Henry T. Greely, Robert C. Green, Stuart Hogarth & Sue Siegel, The Future of Direct-to-Consumer Clinical Genetic Tests, Nature Reviews Genetics, published online June 1, 2011, doi:10.1038/nrg3026

In light of the meeting of the US Food and Drug Administration (FDA) in March 2011 to discuss the regulation of clinical direct-to-consumer (DTC) genetic tests, we have invited five experts to consider the best means of overseeing the ordering and interpretation of these tests. Should these tests be regulated? If so, who, if anyone, should communicate results to consumers?

Other publications by this author

View All

• Foreword
  2012-04-24
• Direct Brain Interventions to "Treat" Disfavored Human Behaviors: Ethical and Social Issues
  2012-03-06
• Remembering the Sheep that Changed the World
  2012-02-28
• Designer Eggs and Stem Cell Sausage
  2012-02-16
• The Equality of Allocation by Lot
  2011-12-02
• Noninvasive Prenatal Diagnosis: Pregnant Women's Interest and Expected Uptake
  2011-10-26
• Reference Guide on Neuroscience
  2011-09-28
• Human/Nonhuman Chimeras: Assessing the Issues
  2011-09-19
• Thoughts on the Eleventh Circuit Health-Care Law Ruling
  2011-08-12
• Law and the Biosciences
  2011-06-06